As a journalist, you know if an interview is going well or not. I've had stinkers - usually the ones where you're asking awkward questions that the interviewee would prefer not to answer, prompting ...
Roblox's CEO has called the problem of predators on the platform an "opportunity", as the company updates its safety measures with age verification checks. Roblox is predominantly used by children and ...
The U.S. Food & Drug Administration (FDA) on Tuesday extended review for Ascendis Pharma A/S‘ (NASDAQ: ASND) New Drug Application (NDA) for TransCon CNP (navepegritide) for children with ...
Touchstone Mid Cap Growth Fund outperformed its benchmark in Q3 2025 despite speculative markets. Discover key drivers and ...
Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
– Prescription Drug User Fee Act (PDUFA) goal date extended by three months to February 28, 2026 COPENHAGEN, Denmark, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today ...
– Prescription Drug User Fee Act (PDUFA) goal date extended by three months to February 28, 2026 COPENHAGEN, Denmark, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today ...
COPENHAGEN, Denmark, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) notified the Company that information submitted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback